Genfleet Therapeutics (shanghai) Inc.
Clinical trials sponsored by Genfleet Therapeutics (shanghai) Inc., explained in plain language.
-
New drug targets 'Undruggable' cancer mutation in major trial
Disease control Recruiting nowThis clinical trial is testing an experimental drug called GFH375 for people with advanced solid tumors that have a specific genetic mutation called KRAS G12D. The study aims to determine if the drug is safe, how it moves through the body, and if it can help shrink tumors. It wil…
Phase: PHASE1, PHASE2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug combo targets 'Undruggable' cancer mutation in advanced patients
Disease control Recruiting nowThis study is testing whether combining the experimental drug GFH375 with either cetuximab or chemotherapy can help control advanced solid tumors that have a specific KRAS G12D mutation. The trial will enroll 126 adults whose cancers have progressed despite standard treatments. R…
Phase: PHASE1, PHASE2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC